cogrx.com (CGTX) - Net earnings per one share growth for the current year

CGTX (cogrx.com) - company brandmark

The annual growth rate of net income per share for Cognition Therapeutics (CGTX) reflects market expectations, with the metric currently standing at 40.90. This trend is driven by stringent FDA oversight and the complexities associated with patenting Alzheimer's treatments. The strategic focus on synapse protection for chronic pathologies ensures perpetual demand. Well-established raw material supply chains, supported by an expanded partner network, maintain the business's stability.

CGTX Cognition Therapeutics Earnings per share growth in current year (07/04/2022 - 11/17/2026)

Comprehensive metric breakdowns and analytics for Cognition Therapeutics (CGTX)

- current quotes and average value forecast:
Summary company analysis:Cognition Therapeutics - CGTX
Brand item of Cognition Therapeutics Inc.

For Cognition Therapeutics (CGTX), whose operations are limited to laboratory research without in-house production, earnings per share dynamics serve as a key indicator of capital management efficiency. By analyzing the year-over-year EPS comparison, investors assess the rate of change in net income, which helps determine the company's fundamental stability and the accuracy of the market valuation of its intellectual assets in the absence of commercial sales.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Inhibikase Therapeutics, Inc. - Net earnings per one share growth for the current year|SAVA: Earnings growth in current year|Earnings per share growth this year ASRT|COYA (coyatherapeutics.com) - Earnings growth in current year|Vistagen (VTGN) - Expected net earnings per share growth this year|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE